Skip to main content
Top
Published in: International Urology and Nephrology 11/2016

01-11-2016 | Nephrology - Original Paper

Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy

Authors: Ying-Xin Xie, Li-Yu He, Xian Chen, Xiao-Fei Peng, Mu-Yao Ye, Yu-Jing Zhao, Wen-Zhe Yan, Chan Liu, Jing Shao, You-Ming Peng

Published in: International Urology and Nephrology | Issue 11/2016

Login to get access

Abstract

Objective

The proteins BAFF, ST6GALNAC2, C1GALT1, and COSMC in peripheral blood mononuclear cells (PBMCs) and plasma levels of IgA1 and galactose-deficient IgA1 (Gd-IgA1) are potential biomarkers for IgAN nephropathy. In this study, we comparatively studied the changes of those biomarkers before and after tonsillectomy.

Methods

Peripheral blood samples were obtained from 16 IgAN patients with pre- and post-tonsillectomy. IgAN was diagnosed based on results from analysis of percutaneous renal biopsy tissue. Peripheral blood samples from three patients without renal diseases (non-IgAN), before and after tonsillectomy, and 16 healthy controls were also examined. BAFF, ST6GALNAC2, C1GALT1, and COSMC mRNA levels in PBMCs were detected using real-time PCR. Plasma IgA1 content was measured by ELISA. Gd-IgA1 levels were determined using the VV lectin-ELISA method.

Results

BAFF, ST6GALNAC2, C1GALT1, and COSMC mRNA levels and the plasma concentrations of IgA1 and Gd-IgA1 in IgAN patients before tonsillectomy were significantly higher than those in healthy controls (P < 0.05). Tonsillectomy significantly increased the expression of BAFF and ST6GALNAC2, and plasma IgA1 level, while it downregulated that of C1GALT1 and COSMC (P < 0.05). However, in non-IgAN patients, tonsillectomy did not affect the mRNA levels of BAFF, ST6GALNAC2, C1GALT1, and COSMC, plasma IgA1 content and Gd-IgA1 level. Positive correlations were established between BAFF and IgA1 (r = 0.604, P < 0.01) and between ST6GALNAC2 and Gd-IgA1 (r = 0.623, P < 0.01).

Conclusions

Tonsillectomy changes the mRNA levels of BAFF, ST6GALNAC2, C1GALT1, and COSMC in PBMCs, as well as the plasma IgA1 level in IgAN patients. BAFF and ST6GALNAC2 might regulate IgA1 secretion and O-glycosylation.
Literature
1.
go back to reference D’Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64(245):709–727PubMed D’Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64(245):709–727PubMed
2.
go back to reference Rifai A, Chen A, Imai H, Millard K (1987) IgA molecular form–pathophysiology correlates: immune complex formation and glomerular deposition. Adv Exp Med Biol 216B:1515–1522PubMed Rifai A, Chen A, Imai H, Millard K (1987) IgA molecular form–pathophysiology correlates: immune complex formation and glomerular deposition. Adv Exp Med Biol 216B:1515–1522PubMed
3.
go back to reference D’Amico G (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24(3):179–196CrossRefPubMed D’Amico G (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24(3):179–196CrossRefPubMed
4.
go back to reference Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Yanagawa H, Matsuzaki K, Horikoshi S, Novak J, Tomino Y (2014) Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One 9(2):e89707CrossRefPubMedPubMedCentral Nakata J, Suzuki Y, Suzuki H, Sato D, Kano T, Yanagawa H, Matsuzaki K, Horikoshi S, Novak J, Tomino Y (2014) Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy. PLoS One 9(2):e89707CrossRefPubMedPubMedCentral
5.
go back to reference Kamei D, Moriyama T, Takei T, Wakai S, Nitta K (2014) Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. Clin Exp Nephrol 18(2):320–328CrossRefPubMed Kamei D, Moriyama T, Takei T, Wakai S, Nitta K (2014) Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. Clin Exp Nephrol 18(2):320–328CrossRefPubMed
6.
go back to reference Yang D, He L, Peng X, Liu H, Peng Y, Yuan S, Liu Y, Chen X, Liu F, Liu C (2016) The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial. Ren Fail 38(2):242–248CrossRefPubMed Yang D, He L, Peng X, Liu H, Peng Y, Yuan S, Liu Y, Chen X, Liu F, Liu C (2016) The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial. Ren Fail 38(2):242–248CrossRefPubMed
7.
go back to reference Liu LL, Wang LN, Jiang Y, Yao L, Dong LP, Li ZL, Li XL (2015) Tonsillectomy for IgA nephropathy: a meta-analysis. Am J Kidney Dis 65(1):80–87CrossRefPubMed Liu LL, Wang LN, Jiang Y, Yao L, Dong LP, Li ZL, Li XL (2015) Tonsillectomy for IgA nephropathy: a meta-analysis. Am J Kidney Dis 65(1):80–87CrossRefPubMed
8.
9.
go back to reference Lahiri A, Pochard P, Le Pottier L, Tobon GJ, Bendaoud B, Youinou P, Pers JO (2012) The complexity of the BAFF TNF-family members: implications for autoimmunity. J Autoimmun 39(3):189–198CrossRefPubMed Lahiri A, Pochard P, Le Pottier L, Tobon GJ, Bendaoud B, Youinou P, Pers JO (2012) The complexity of the BAFF TNF-family members: implications for autoimmunity. J Autoimmun 39(3):189–198CrossRefPubMed
10.
go back to reference Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A (2012) Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J Immunol 188(12):6071–6083CrossRefPubMedPubMedCentral Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A (2012) Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J Immunol 188(12):6071–6083CrossRefPubMedPubMedCentral
11.
go back to reference Bolkun L, Lemancewicz D, Jablonska E, Kulczynska A, Bolkun-Skornicka U, Kloczko J, Dzieciol J (2014) BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma. Ann Hematol 93(4):635–644CrossRefPubMed Bolkun L, Lemancewicz D, Jablonska E, Kulczynska A, Bolkun-Skornicka U, Kloczko J, Dzieciol J (2014) BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma. Ann Hematol 93(4):635–644CrossRefPubMed
12.
go back to reference Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Ratajczak-Wrona W, Dzieciol J, Kloczko J (2015) The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. Ann Hematol 94(1):35–43CrossRefPubMed Bolkun L, Lemancewicz D, Jablonska E, Szumowska A, Bolkun-Skornicka U, Ratajczak-Wrona W, Dzieciol J, Kloczko J (2015) The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features. Ann Hematol 94(1):35–43CrossRefPubMed
13.
go back to reference Bergamin F, Vincent IE, Summerfield A, McCullough KC (2007) Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol 37(11):3122–3130CrossRefPubMed Bergamin F, Vincent IE, Summerfield A, McCullough KC (2007) Essential role of antigen-presenting cell-derived BAFF for antibody responses. Eur J Immunol 37(11):3122–3130CrossRefPubMed
14.
go back to reference Pieper K, Grimbacher B, Eibel H (2013) B-cell biology and development. J Allergy Clin Immunol 131(4):959–971CrossRefPubMed Pieper K, Grimbacher B, Eibel H (2013) B-cell biology and development. J Allergy Clin Immunol 131(4):959–971CrossRefPubMed
15.
go back to reference McCarthy DD, Kujawa J, Wilson C, Papandile A, Poreci U, Porfilio EA, Ward L, Lawson MA, Macpherson AJ, McCoy KD, Pei Y, Novak L, Lee JY, Julian BA, Novak J, Ranger A, Gommerman JL, Browning JL (2011) Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest 121(10):3991–4002CrossRefPubMedPubMedCentral McCarthy DD, Kujawa J, Wilson C, Papandile A, Poreci U, Porfilio EA, Ward L, Lawson MA, Macpherson AJ, McCoy KD, Pei Y, Novak L, Lee JY, Julian BA, Novak J, Ranger A, Gommerman JL, Browning JL (2011) Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest 121(10):3991–4002CrossRefPubMedPubMedCentral
16.
go back to reference Xin G, Shi W, Xu LX, Su Y, Yan LJ, Li KS (2013) Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J Nephrol 26(4):683–690CrossRefPubMed Xin G, Shi W, Xu LX, Su Y, Yan LJ, Li KS (2013) Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J Nephrol 26(4):683–690CrossRefPubMed
17.
go back to reference Takahashi K, Smith AD, Poulsen K, Kilian M, Julian BA, Mestecky J, Novak J, Renfrow MB (2012) Naturally occurring structural isomers in serum IgA1 o-glycosylation. J Proteome Res 11(2):692–702CrossRefPubMed Takahashi K, Smith AD, Poulsen K, Kilian M, Julian BA, Mestecky J, Novak J, Renfrow MB (2012) Naturally occurring structural isomers in serum IgA1 o-glycosylation. J Proteome Res 11(2):692–702CrossRefPubMed
18.
go back to reference Narimatsu Y, Kubota T, Furukawa S, Morii H, Narimatsu H, Yamasaki K (2010) Effect of glycosylation on cis/trans isomerization of prolines in IgA1-hinge peptide. J Am Chem Soc 132(16):5548–5549CrossRefPubMed Narimatsu Y, Kubota T, Furukawa S, Morii H, Narimatsu H, Yamasaki K (2010) Effect of glycosylation on cis/trans isomerization of prolines in IgA1-hinge peptide. J Am Chem Soc 132(16):5548–5549CrossRefPubMed
19.
go back to reference Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71(11):1148–1154CrossRefPubMed Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71(11):1148–1154CrossRefPubMed
20.
go back to reference Takahashi K, Raska M, Horynova MS, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J (2014) Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. PLoS One 9(2):e99026CrossRefPubMedPubMedCentral Takahashi K, Raska M, Horynova MS, Hall SD, Poulsen K, Kilian M, Hiki Y, Yuzawa Y, Moldoveanu Z, Julian BA, Renfrow MB, Novak J (2014) Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. PLoS One 9(2):e99026CrossRefPubMedPubMedCentral
21.
go back to reference Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22(10):1795–1803CrossRefPubMedPubMedCentral Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22(10):1795–1803CrossRefPubMedPubMedCentral
22.
go back to reference Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Lai FM, Tang SC (2008) Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294(4):F945–F955CrossRefPubMed Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Lai FM, Tang SC (2008) Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294(4):F945–F955CrossRefPubMed
23.
go back to reference Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Tam KY, Xiao J, Lai FM, Tang SC (2009) Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24(1):62–72CrossRefPubMed Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Tam KY, Xiao J, Lai FM, Tang SC (2009) Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24(1):62–72CrossRefPubMed
24.
go back to reference Suzuki H, Raska M, Yamada K, Moldoveanu Z, Julian BA, Wyatt RJ, Tomino Y, Gharavi AG, Novak J (2014) Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem 289(8):5330–5339CrossRefPubMed Suzuki H, Raska M, Yamada K, Moldoveanu Z, Julian BA, Wyatt RJ, Tomino Y, Gharavi AG, Novak J (2014) Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem 289(8):5330–5339CrossRefPubMed
25.
go back to reference Allen AC, Topham PS, Harper SJ, Feehally J (1997) Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12(4):701–706CrossRefPubMed Allen AC, Topham PS, Harper SJ, Feehally J (1997) Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 12(4):701–706CrossRefPubMed
26.
go back to reference Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, Cerullo G, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frasca G, Schena FP, Amoroso A, European Ig ANC (2009) Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 22(1):152–159PubMed Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, Cerullo G, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frasca G, Schena FP, Amoroso A, European Ig ANC (2009) Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 22(1):152–159PubMed
27.
go back to reference Ji L, Chen X, Zhong X, Li Z, Yang L, Fan J, Tang W, Qin W (2014) Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy. BMC Complement Altern Med 14:195CrossRefPubMedPubMedCentral Ji L, Chen X, Zhong X, Li Z, Yang L, Fan J, Tang W, Qin W (2014) Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy. BMC Complement Altern Med 14:195CrossRefPubMedPubMedCentral
28.
go back to reference Barratt J, Smith AC, Feehally J (2007) The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) 12(3):275–284CrossRef Barratt J, Smith AC, Feehally J (2007) The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton) 12(3):275–284CrossRef
29.
go back to reference Shao J, Peng Y, He L, Liu H, Chen X, Peng X (2014) Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients. Hum Immunol 75(10):1034–1039CrossRefPubMed Shao J, Peng Y, He L, Liu H, Chen X, Peng X (2014) Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients. Hum Immunol 75(10):1034–1039CrossRefPubMed
30.
go back to reference Ju T, Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 99(26):16613–16618CrossRefPubMedPubMedCentral Ju T, Cummings RD (2002) A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A 99(26):16613–16618CrossRefPubMedPubMedCentral
Metadata
Title
Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy
Authors
Ying-Xin Xie
Li-Yu He
Xian Chen
Xiao-Fei Peng
Mu-Yao Ye
Yu-Jing Zhao
Wen-Zhe Yan
Chan Liu
Jing Shao
You-Ming Peng
Publication date
01-11-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 11/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1372-2

Other articles of this Issue 11/2016

International Urology and Nephrology 11/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.